Claforan Related Published Studies
Well-designed clinical trials related to Claforan (Cefotaxime)
Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. [2005.11.21]
The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. [2005.11]
Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. [2005.11]
[Incidence of infected surgical wound and prophylaxis with cefotaxime in cesarean section] [2005.10]
Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors. [2005.07]
An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. [2004.11.15]
Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis. [2003.09]
A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. [2003.01]
Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial. [2002.08]
Cefepime versus cefotaxime for empirical treatment of bacterial pneumonia in HIV-infected patients: an open, randomized trial. [2001.10]
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery. [2001.09]
Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever. [2001.02]
Effects of intraocular cefotaxime on the human corneal endothelium. [2001.02]
[Cost-effectiveness analysis of ceftriaxone and cefotaxime in the treatment of community-acquired pneumonia] [2000.07]
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. [2000.04]
The comparative efficacy of intravenous cefotaxime and trimethoprim/sulfamethoxazole in preventing infection after neurosurgery: a prospective, randomized study. Brisbane Neurosurgical Infection Group. [2000.02]
An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group. [1999.09]
Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. [1999.07]
Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery. [1999.03]
Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections. [1998.12]
Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. [1998.12]
[Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection] [1998.09]
[Prospective randomized trial of meropenem versus cefotaxime and metronidazole in the treatment of intraabdominal infections] [1998.06.27]
Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. [1998.03]
Prophylactic antibiotics administration head and neck cancer surgery with major flap reconstruction: 1-day cefoperazone versus 5-day cefotaxime. [1998]
[Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections] [1997.07]
One bolus dose of gentamicin and early oral therapy versus cefotaxime and subsequent oral therapy in the treatment of febrile urinary tract infection. [1997.06]
Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study. [1997.06]
A multi-centre study to compare meropenem and cefotaxime and metronidazole in the treatment of hospitalized patients with serious infections. [1997.05]
Pharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titers. [1997.05]
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial. [1997.03]
Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniae. [1996.12]
Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections. [1996.11]
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. [1996.10]
Comparison of ceftriaxone versus cefotaxime for childhood upper urinary tract infections. [1996.02]
A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patients. [1995.11]
[A randomized controlled clinical trial of sulperazone as compared with cefotaxime in the treatment of bacterial infections] [1995.10]
[Cefminox versus cefotaxime in the treatment of complicated urinary tract infection] [1995.09]
Comparison of cefotaxime plus metronidazole versus cefoxitin for prevention of wound infection after abdominal surgery. [1995.09]
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group. [1995.07]
A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. [1995.07]
Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group. [1995.05]
Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study. [1995.05]
Retrospective analysis of the efficacy of cefotaxime sodium dosed twice daily. The Swedish experience. [1995.05]
Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections. [1995.05]
Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. [1995.04]
A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients. [1995.04]
Ceftriaxone once daily compared with four daily doses of cefotaxime in the treatment of severe gram-negative septicemia or pyemia: a randomized study. [1995.03]
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. [1995.03]
Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology. [1995.01]
Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis. [1995]
Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial. [1994.11]
[Treatment of lower respiratory tract infections including pneumonia. Comparative study with i.vl cefotaxime/oral cefixime versus parenteral cefotaxime] [1994.10.10]
Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea. [1994.04]
Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections. [1993.11]
Cefepime versus cefotaxime in the treatment of lower respiratory tract infections. [1993.11]
Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea. [1993.09]
Amoxycillin and clavulanic acid versus cefotaxime and metronidazole as antibiotic prophylaxis in elective colorectal resectional surgery. [1993.03]
Effectiveness of single dose prophylaxis with cefotaxime and metronidazole compared with three doses of cefotaxime alone in elective colorectal surgery. [1993.03]
[The treatment of infectious endocarditis. Cefotaxime versus "traditional" medical management] [1993.01]
Cefotaxime prophylaxis in major non-contaminated head and neck surgery: one-day vs. seven-day therapy. [1993.01]
Effects of imipenem, cefotaxime and cotrimoxazole on aerobic microbial colonization of the digestive tract. [1993]
Timing of antibiotic prophylaxis with cefotaxime for prostatic resection: better in the operative period or at urethral catheter removal? [1992.10]
Comparative study of single-dose cefotaxime and multiple doses of cefoxitin and cefazolin as prophylaxis in gynecologic surgery. [1992.10]
Efficacy of a low dose of cefotaxime in serious chest infections. [1992.05]
A multicenter comparison of oral lomefloxacin versus parenteral cefotaxime as prophylactic agents in transurethral surgery. [1992.04.06]
Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime. [1992.04]
[The effectiveness of preventive use of antibiotics in Cesarean section with a single dose: comparison of cefotaxime with amoxicillin plus clavulanic acid] [1992.02]
Comparison of the efficacy and adverse effect profile of cefotaxime and ceftriaxone in ICU patients with susceptible infections. [1992.01]
A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections. [1992.01]
Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infections. [1992.01]
Randomized comparison of cefotaxime and ceftriaxone in patients with uncomplicated gonorrhea. [1991.09]
Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. [1991.07]
A randomized clinical trial of ampicillin, gentamicin and clindamycin versus cefotaxime and clindamycin in children with ruptured appendicitis. [1991.05]
Multicenter trial of prophylaxis with clindamycin plus aztreonam or cefotaxime in gynecologic surgery. [1991.05]
Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. [1991.02]
[Comparison of 2 antibiotic combinations used for peritonitis. Cefotaxime-clindamycin versus cefotaxime-metronidazole] [1991.01.19]
Outcome of a ceftriaxone/cefotaxime interchange programme in a major teaching hospital. [1991]
Nosocomial pneumonia: comparative multicentre trial between monotherapy with cefotaxime and treatment with antibiotic combinations. [1991]
Short-term cefotaxime prophylaxis reduces the failure rate in lower limb amputations. [1990.10]
Pefloxacin compared with cefotaxime for treating men with uncomplicated gonococcal urethritis. [1990.10]
Antibiotic prophylaxis with cefotaxime in endoscopic extraction of upper urinary tract stones: a randomized study. The Cefotaxime Cooperative Group. [1990.09]
Prevention of bacterial colonization of the respiratory tract and stomach of mechanically ventilated patients by a novel regimen of selective decontamination in combination with initial systemic cefotaxime. [1990.09]
Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease. [1990.09]
Short-course cefotaxime compared with five-day co-amoxyclav in acute otitis media in children. [1990.09]
Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate. [1990.09]
[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units] [1990.04.04]
A comparison of aztreonam/metronidazole and cefotaxime/metronidazole in elective colorectal surgery: antimicrobial prophylaxis must include gram-positive cover. [1990.04]
Study of the influence of protein binding on serum bactericidal titres and killing rates in volunteers receiving ceftazidime, cefotaxime and ceftriaxone. [1990.04]
Cefotaxime for cesarean section prophylaxis in labor. Intravenous administration vs. lavage. [1990.03]
Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients. [1990.03]
Well-designed clinical trials possibly related to Claforan (Cefotaxime)
A randomised, double-blind trial comparing ceftobiprole medocaril with
ceftriaxone with or without linezolid for the treatment of patients with
community-acquired pneumonia requiring hospitalisation. [2012]
Comparative bioavailability study of cefuroxime axetil (equivalent to 500 mg cefuroxime/tablet) tablets (Zednad(R) versus Zinnat(R)) in healthy male volunteers. [2011.09]
Slow initial beta-lactam infusion and oral paracetamol to treat childhood bacterial meningitis: a randomised, controlled trial. [2011.08]
5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study. [2011.05.28]
Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. [2011.05]
The role of intestinal colonization with gram-negative bacteria as a source for intensive care unit-acquired bacteremia. [2011.05]
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. [2011.04]
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. [2011.04]
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia. [2011.04]
Review of ceftaroline fosamil microbiology: integrated FOCUS studies. [2011.04]
|
